SCHEMBL4024245

SCHEMBL4024245

N#CCCCn1c2c(c3cc(C(=O)O)ccc31)CCCC2

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.50
SCARB1 Q8WTV0 5/20 0.49
KDM4E B2RXH2 3/20 0.47
HSD17B10 Q99714 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
NPC1 O15118 2/20 0.45
PTGDR2 Q9Y5Y4 4/20 0.44
ACLY P53396 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
RORC P51449 1/20 0.43
MEN1 O00255 1/20 0.43
GLA P06280 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026658 0.90 NPC1 (0.57) SCARB1KDM4EHSD17B10ALDH1A1NPC1
SCHEMBL4028396 0.87 SCARB1 (0.66) SCARB1HSD17B10NPC1PTGDR2HDAC1
SCHEMBL10732414 0.81 CHRM2 (0.64) FABP4SCARB1KDM4EHSD17B10ALDH1A1
SCHEMBL6753135 0.79 KDM4E (0.67) FABP4SCARB1KDM4EHSD17B10ALDH1A1
SCHEMBL27542798 0.76 RAB9A (0.54) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL4029779 0.76 SCARB1 (0.82) FABP4SCARB1KDM4EHSD17B10ALDH1A1
SCHEMBL4024465 0.75 CNR2 (0.56) FABP4SCARB1KDM4EHSD17B10ALDH1A1
SCHEMBL25439045 0.74 HSD17B10 (0.52) FABP4SCARB1KDM4EHSD17B10ALDH1A1
SCHEMBL31554288 0.74 FABP4 (0.63) FABP4HDAC1HDAC6
SCHEMBL6682174 0.73 FABP4 (0.69) FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed